Why Investors Are Buzzing About Threshold Pharmaceuticals, Enbridge, Facebook and More

Cempra Inc (NASDAQ:CEMP) shares are 2% in the green today after the company announced interim results from a Phase 2 Study of Solithromycin. According to the company, pre/post treatment biopsies show that the mean NAS reduction clocked in at 1.3 points after 90 days of treatment with solithromycin. The investigative drug was also well tolerated. Given that the study size was somewhat small with just six patients, the company plans to continue the phase 2 study so as to obtain data from up to 15 NASH patients, with enrollment expected to be completed in the first quarter of 2017. Smart money sentiment towards Cempra Inc (NASDAQ:CEMP) was stable in the second quarter. 14 funds in our database were long Cempra Inc (NASDAQ:CEMP) at the end of June, unchanged from the end of March.

According to the Wall Street Journal, Facebook Inc (NASDAQ:FB) plans to launch a major ad campaign replete with TV commercials and billboards to get more of its users to use the company’s live stream video feature. The ad campaign is part of CEO Mark Zuckerberg’s goal of making Facebook into more of a ‘video first’ company. Seeing as how video ads are generally more lucrative than text ads, Facebook shareholders could benefit greatly if more people use the feature. Stephen Mandel‘s Lone Pine Capital reported holding a stake of over 10.9 million shares in Facebook Inc (NASDAQ:FB) as of the end of June. That was down by around 5% from the fund’s holding in the social media company at the end of March.

Traders are watching Cisco Systems, Inc. (NASDAQ:CSCO) today (and various cybersecurity stocks) after the company’s CEO Chuck Robbins made an appearance on CNBC’s Mad Money, stating that his company will focus more on the growing field of cybersecurity and the cloud. Robbins also added that Cisco’s dividend is attractive, as it currently pays out an annual yield of 3.3%, double the 10-year yield. The number of funds in our system with holdings in Cisco Systems, Inc. (NASDAQ:CSCO) fell by four during the second quarter to 61 at the end of June.

Disclosure: None